Page last updated: 2024-11-05

camphoroquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

camphoroquinone: a natural monoterpene, non-aromatic quinone; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bornane-2,3-dione : A bornane monoterpenoid that is bicyclo[2.2.1]heptane substituted by methyl groups at positions 1, 7 and 7 and oxo groups at positions 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25208
CHEMBL ID301431
CHEBI ID34607
SCHEMBL ID15201
MeSH IDM0139141

Synonyms (61)

Synonym
10373-78-1
1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione
bicyclo[2.2.1]heptane-2,3-dione, 1,7,7-trimethyl-, (1s)-
CHEBI:34607 ,
bornane-2,3-dione
camphor quinone
dl-camphoroquinone
dl-camphorquinone
bicyclo[2.2.1]heptane-2,3-dione, 1,7,7-trimethyl-, (1r)-
bicyclo[2.2.1]heptane-2,3-dione, 1,7,7-trimethyl-
1,7,7-trimethylnorbornane-2,3-dione
nsc402031
nsc-402031
bicyclo[2.2.1]heptane-2, 1,7,7-trimethyl-
465-29-2
camphoquinone
nsc-285
camphoroquinone
camphorquinone ,
2,3-bornanedione
nsc285
1,7,7-trimethylbicyclo(2.2.1)heptan-2,3-dione
(1s)-(+)-2,3-bornanedione
C1660
(+/-)-camphorquinone
CHEMBL301431
LMPR0102120030
1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione bornane-2,3-dione
STK803340
AKOS001042401
NCGC00260507-01
dtxsid7049394 ,
tox21_202961
cas-10373-78-1
dtxcid4029353
BBL012870
FT-0605273
FT-0624462
FT-0623434
FT-0625447
FT-0625448
AM20070444
2,3-bornanedione;1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione
AKOS016037995
SCHEMBL15201
1,7,7-trimethyl-bicyclo[2.2.1]heptane-2,3-dione
(+/-) camphorquinone
1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione #
3-ketocamphor
J-610003
rac-camphorquinone
mfcd00064160
J-520412
N11921
Z56943556
Q2698440
AS-15119
EN300-17476
SY036381
A849257
CS-0127185

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The cytotoxic effects of the photosensitizers on both human submandibular gland (HSG) adenocarcinoma cell line and primary human gingival fibroblast (HGF) showed that the 50% toxic concentration (TC(50)) declined in the order: CQ>BP>9-F>BZ."( The production of reactive oxygen species by irradiated camphorquinone-related photosensitizers and their effect on cytotoxicity.
Atsumi, T; Fujisawa, S; Iwakura, I; Ueha, T, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" Concentrations leading to 50% cell survival (TC50 values) were calculated from fitted dose-response curves."( Responses of L929 mouse fibroblasts, primary and immortalized bovine dental papilla-derived cell lines to dental resin components.
Hiller, KA; Schmalz, G; Schweikl, H; Thonemann, B, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
bornane monoterpenoid
carbobicyclic compoundA bicyclic compound in which all the ring atoms are carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency27.61180.006038.004119,952.5996AID1159521
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency55.09270.003041.611522,387.1992AID1159552
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency10.99240.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID23714Partition coefficient (logP)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID203473Binding constant against bovine serum albumin1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID23978Capacity ratio (log k'w)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (236)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (2.97)18.7374
1990's23 (9.75)18.2507
2000's101 (42.80)29.6817
2010's98 (41.53)24.3611
2020's7 (2.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.46 (24.57)
Research Supply Index5.51 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index61.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (2.02%)6.00%
Case Studies3 (1.21%)4.05%
Observational0 (0.00%)0.25%
Other239 (96.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]